Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many organizations, social risk data remains siloed, underoperationalized, and inactionable. On a recent webinar, MedeAnalytics and Socially Determined demonstrated how health plans can integrate member-level social risk data directly into payer analytics workflows, alongside claims, pharmacy,…

Read More

GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers must balance this potential with challenges such as high upfront spend, adherence issues, and determining which patients will benefit most. Read a more in-depth overview of these considerations in our previous blog post. Managing these…

Read More

Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally developed for diabetes and now widely used for weight management, are rapidly reshaping clinical care with far-reaching impacts on chronic disease management, weight loss, and cardiovascular health. Despite long-term benefits, the prescribing of GLP-1s must…

Read More

Key takeaways from The Sequoia Project’s 2025 Annual Meeting to speed up healthcare data interoperability   I recently attended The Sequoia Project’s 2025 Annual Meeting in Nashville. The Sequoia Project was formed in 2012 with the launch of its first initiative, a federal health information network. They help healthcare organizations and government bodies accelerate the…

Read More
Discover how Accountable Care Organizations can thrive amidst healthcare challenges.

In the ever-evolving landscape of healthcare, Accountable Care Organizations (ACOs) find themselves at the epicenter of a transformative era. Recently, we facilitated an insightful dialogue with healthcare experts Lynn Carroll, COO of HSBlox, and Brian Norris, MBA, RN, FHIMSS, Vice President & Managing Director of Strategic Consulting at MedeAnalytics, to shed light on the future…

Read More
Medicare Rule Changes 2026: What Healthcare Organizations Need to Know

The Centers for Medicare & Medicaid Services (CMS) has recently unveiled significant proposed changes to Medicare Advantage (MA), Medicare Prescription Drug (Part D), and Medicaid programs. Announced on November 26, 2024, these updates aim to enhance affordability, transparency, and equity in healthcare delivery. The implications of the latest CMS rule changes are vast, presenting both…

Read More

The transition from CMS-HCC V24 to V28 heralds a significant shift in risk adjustment methodologies and emphasizes improved accuracy and granularity, promising more equitable resource distribution and significant financial implications for Medicare Advantage plans, ACOs, and other healthcare entities. If you have not started moving toward this new model, there is no time to waste.…

Read More